MBX Biosciences Inc
MBX Biosciences Inc (MBX) Unusual Options Activity Today
MBX options volume power reached 1x on the previous trading day. The highest reading was on the $60 PUT expiring 2026-11-20.
Read more
Checking MBX unusual options activity helps you spot when traders are making outsized bets on MBX Biosciences Inc before the broader market catches on. MBX Biosciences Inc's unusual options activity flags contracts trading at multiples of their average daily volume, often signaling that informed money is positioning ahead of a catalyst. Use our scanner to monitor MBX unusual options activity today and surface the prints that deserve a second look.
Unusual options flow typically refers to trades where volume vastly exceeds open interest at a given strike, or where total contract volume on a name spikes well above its norm. Watching MBX unusual options flow today can reveal large block trades, sweeps across exchanges, and aggressive directional bets. Tracking MBX unusual options volume across calls and puts helps you separate hedging activity from genuinely speculative positioning, and MBX unusual options flow data becomes especially valuable around earnings, product launches, and macro events.
MBX Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of precision peptide therapies for the treatment of endocrine and metabolic disorders. Its lead product candidate is MBX 2109, a parathyroid hormone peptide prodrug, which is in Phase 2 clinical trial designed as a potential long-acting hormone replacement therapy for the treatment of chronic hypoparathyroidism. The company is also developing MBX 1416, a long-acting glucagon-like peptide-1 (GLP-1) receptor antagonist that is in Phase 1 clinical trial designed as a potential therapy for post-bariatric hypoglycemia, a chronic complication of bariatric surgery.
In addition, it is developing MBX 4291, a lead obesity product candidate, which is in investigational new drug-enabling studies designed as a long-acting and highly potent GLP-1 and glucose-dependent insulinotropic polypeptide receptor co-agonist prodrug for treating obesity and co-morbidities. The company was founded in 2018 and is based in Carmel, Indiana.
Catalysts rarely arrive without a footprint, and MBX unusual options activity is often where that footprint shows up first. Our scanner tracks MBX Biosciences Inc's unusual options flow in real time, ranks prints by volume-to-open-interest, premium spent, and aggressor side, and separates real conviction from noise. Whether you're looking at MBX unusual options volume on the call side or chasing put sweeps, MBX Biosciences Inc's unusual options flow today is one click away, so put it on your radar before the headlines hit.
| 60.00 | 2.80 | 5.20 | 4.00 | 99% | 9 | 129 | 6.98% |
| 65.00 | 0.70 | 3.30 | 2.00 | 90% | 2 | 71 | 2.82% |
| 15.00 | 40.10 | 44.80 | 42.45 | 51% | 0 | 0 | — |
| 17.50 | 37.60 | 42.30 | 39.95 | 67% | 0 | 0 | — |
| 20.00 | 35.10 | 39.80 | 37.45 | 53% | 0 | 0 | — |
| 60.00 | 4.50 | 6.60 | 5.55 | 83% | 1 | 27 | 3.70% |
| 15.00 | — | 4.90 | 4.90 | 769% | 0 | 0 | — |
| 17.50 | — | 4.90 | 4.90 | 681% | 0 | 0 | — |
| 20.00 | — | 4.90 | 4.90 | 610% | 0 | 0 | — |
| 22.50 | — | 4.90 | 4.90 | 550% | 0 | 0 | — |
As of September 28, 2026
Spot unusual options activity before it moves
Track MBX options flow across every expiration, filter by volume power, and find the setups with abnormal activity before the trade is gone.
Start your 14-day free trial→